Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy

Pediatric Infectious Disease Journal

Volumn 17, Issue 6, 1998, Pages 489-494

  Koch, William C ^a   Harger, James H ^b   Barnstein, Brian ^a   Adler, Stuart P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital infection; Intrauterine infection; Parvovirus B19; Polymerase chain reaction; Pregnancy

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; HUMAN; INTRAUTERINE INFECTION; MATERNAL AGE; MATERNAL DISEASE; NEWBORN; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME;

EID: 0031833758     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199806000-00011     Document Type: Article

References (22)

1. Anand A, Gray ES, Brown T, Clewly JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-6.
2. Mortimer PP, Cohen BJ, Buckley MM, et al. Human parvovirus and the fetus [Letter]. Lancet 1985;2:1012.
3. Schwarz TF, Roggendorf M, Hottentrager B, et al. Human parvovirus B19 infection in pregnancy [Letter]. Lancet 1988; 2:566-7.
4. Hall SM, Cohen BJ, Mortimer PP, et al. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990;300:1166-70.
5. Rodis JF, Quinn DL, Gary GW, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990;163:1168-71.
6. Torok TJ, Anderson LJ, Gary GW, Yoder CGT. Reproductive outcomes following human parvovirus B19 infection in pregnancy [Abstract 1374]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991:328.
7. Gratacos E, Torres PJ, Vidal J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171:1360-3.
8. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998;91:413-20.
9. Torok TJ, Wang QY, Gary GW, Yang CP, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992;14:149-55.
10. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34:603-8.
11. Koch WC. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. J Virol Methods 1995;55:67-82.
12. Soderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995;171:710-13.
13. Koch WC, Adler SP. Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J Clin Microbiol 1990;28:65-9.
14. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
16. Knott PD, Welply GAC, Anderson MJ. Serologically proved intrauterine infection with parvovirus. Br Med J 1984;289: 1660.
17. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in neonatal susceptibility to infection. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: Saunders, 1995: 20-98.
18. Livingston RA, Hutton N, Halsey NA, Kline RL, Joyner M, Quinn TC. Human immunodeficiency virus-specific IgA in infants born to human immunodeficiency virus-seropositive women. Arch Pediatr Adolesc Med 1995;149:503-7.
19. Koch WC, Adler SP, Harger J. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr Infect Dis J 1993;12:747-50.
20. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995;171:1115-21.
21. Guidozzi F, Ballot D, Rothberg AD. Human B19 parvovirus infection in an obstetric population: a prospective study determining fetal outcome. J Reprod Med 1994;39:36-8.
22. Bansal GP, Hatfield JA, Dunn FE, et al. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993; 167:1034-44.